華潤醫療(01515.HK)公佈中期業績 淨利潤達1.1億元 爭取達成年初預定全年經營目標
格隆匯8月28日丨華潤醫療(01515.HK)公佈,截至2020年6月30日止6個月,公司實現營業收入9.07億元人民幣,期間淨利潤達1.1億元,每股盈利0.09元。
截至2020年6月30日,集團在中國9個省、市共管理運營106家醫療機構,集團成員醫院門診量和住院量分別為3,148,940和93,761人次。
在應對新冠病毒疫情方面,截至2020年3月底,華潤醫療全國所有醫療機構共計治癒患者逾500人;緊急開發上線“華潤醫療線上諮詢平台”並由華潤醫療旗下多家醫療機構20多個專業科室、340多名醫師輪流排班,24小時免費提供線上諮詢,線上資訊平台共計逾4,000人線上問診。
2020年下半年,公司將繼續以“做強專科,做好品牌”為核心目標,強化下屬醫療機構中規模大、品牌優、效益好的現有優勢學科;在完善患者服務體系方面,公司將繼續優化潤心患者服務體系,打造華潤醫療服務品牌及提升美譽度。公司亦將持續創新醫療+互聯網產品,進一步方便患者就醫。在後疫情時期,公司在保持常規性抗疫的基礎上了,力爭加速恢復下屬醫院的經營及收入,6月下屬醫院在收入端已經基本恢復到去年同期水平,下半年爭取達成年初預定的全年經營目標。其他方面,預計在第三季度完成京煤醫院的重組交易;在下屬腦科集團的發展方面,亦計劃在年內儘快推進華南地區兩家醫院的專科性改革。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.